Stay updated with breaking news from Confidence Interval. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the U.S. Food and Drug Administration (FDA) has granted...
In this population cohort study, patients with gout who used sodium-glucose cotransporter-2 inhibitors (SGLT2is) experienced fewer recurrent flares than those using dipeptidyl peptidase 4 inhibitors (DPP-4is). Those who used SGLT2 inhibitors also presented to the emergency department (ED) less frequently for gout-related visits than those using DPP-4is. Evidence Rating Level: 1 (Excellent) Study Rundown: Gout is a
1. In this randomized controlled trial, zilebesiran resulted in reduced serum angiotensinogen levels and lowered blood pressure among patients with hypertension as compared to a placebo. 2. The effect of zilebesiran on blood pressure was consistent in a subgroup with a high salt diet as well as with co-administration with irbesartan. Evidence Rating Level: 1
1. In this observational study, long-acting antiretroviral therapy (LA-ART) was effective at maintaining virologic suppression in persons living with human immunodeficiency virus (PLWH) with preexisting suppression. 2. Long-acting antiretroviral therapy was also effective at demonstrating virologic suppression in PLWH with viremia. Evidence Rating Level: 1 (Excellent) Study Rundown: Daily oral ART for the treatment of
Approved with EC Authorisation for the Treatment of Patients with Metastatic Castration Resistant Prostate Cancer with BRCA1/2 Mutations Approval for